The worldwide COVID-19 pandemic has affected the operation of health care systems. The direct impact of obstructive sleep apnea (OSA) on COVID-19 infection outcome remains to be elucidated. However, the coincidence of common risk factors for OSA and severe COVID-19 suggests that patients with OSA receiving positive airway pressure therapy may have an advantage relative to those untreated when confronted with a COVID-19 infection. The ongoing COVID-19 pandemic has led to a substantial reduction of sleep medicine services, and the long-term consequences may be considerable. New strategies for the management of sleep disorders are needed to overcome the current underdiagnosis and delay of treatment.
Keywords: CPAP; Delivery of health care; Diagnosis; Mandibular advancement device; Obstructive sleep apnea; Polysomnography; SARS-COV2; Sleep test.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.